register

News - MedTech & Diagnostics

Medtronic and Lumeon partner for value-based care platform

Health Industry Hub | December 11, 2019 |

Lumeon, the leader in Care Pathway Management (CPM) has entered a strategic partnership with Medtronic to support Medtronic’s healthcare provider customers in their transition to efficient, value-based care models.

Through the partnership, Medtronic’s Integrated Healthcare Solutions (IHS) business will leverage Lumeon’s leading CPM Platform to operationalise care pathways for surgery optimisation and chronic disease management in Europe. These pathways allow providers to create more effective care coordination that reduces the cost of care delivery while minimising unwarranted variation in care.

Medtronic IHS aims to enhance the efficiency and effectiveness of patient care settings, such as cardiac catheterisation labs and operating rooms, while optimising patient pathways and care delivery from the time a patient is referred for treatment to the time he or she has fully recovered.

“As the global healthcare market undergoes a transition from activity-based reimbursement to outcome-based reimbursement, providers are faced with the challenge of reinventing their business models while delivering care that ensures high-quality clinical, operational, and financial outcomes,” said Robbie Hughes, founder and CEO at Lumeon. “We are proud to be working with Medtronic, a company with a well-earned reputation in value-based care models, to help providers master that transition.”

Health Industry Hub offers solutions for vendors and suppliers servicing the industry. Differentiate your business, build thought leadership and boost network growth by reaching the Australian Pharma, MedTech and Biotech industry professionals.

“We are partnering with over 100 hospitals in Europe to develop evidence-based, best practice-informed pathways that deliver superior outcomes for the lowest possible cost,” said Frederic Noël, vice president, Medtronic IHS EMEA. “To help our customers embed these pathways in daily practice and apply them at scale, across their patient groups, we need more than pathway reference models and change management services. We must provide them with solutions to digitalise the pathway, and automate and orchestrate multi-disciplinary care delivery, leveraging Lumeon’s CPM platform.”

Lumeon’s CPM platform ensures that every patient stays on a personalised plan of care throughout his or her entire healthcare journey. It leverages intelligent automation and orchestration to manage a shared plan of care across multiple teams and settings, automatically adjusting activities and deploying the right resource required for each individual patient in real-time.

Register FREE to receive the latest news, innovations and insights from Health Industry Hub; the only one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.


Leadership & Management

David Henderson appointed Takeda Oceania Country Head

David Henderson appointed Takeda Oceania Country Head

Health Industry Hub | August 10, 2026 |

David Henderson has been appointed Country Head for Takeda Oceania, succeeding Dave Pearce, as the pharmaceutical company continues to reshape […]

More


News - Pharmaceuticals

GBMA puts medicine shortages on the table as strategic agreement talks begin

GBMA puts medicine shortages on the table as strategic agreement talks begin

Health Industry Hub | August 10, 2026 |

As the Generic and Biosimilar Medicines Association (GBMA) begins negotiations with government on the next strategic agreement, it has unveiled […]

More


News - MedTech & Diagnostics

Australia sets a new course for prostate cancer detection

Australia sets a new course for prostate cancer detection

Health Industry Hub | August 10, 2026 |

Australia has become one of the first countries in the world to adopt a modern, evidence-based framework for the early […]

More


News - Pharmaceuticals

IVF success rates climb as ART sector faces major accreditation overhaul

IVF success rates climb as ART sector faces major accreditation overhaul

Health Industry Hub | August 10, 2026 |

Australians undergoing in vitro fertilisation (IVF) are now more likely to take home a baby than they were five years […]

More


This content is copyright protected. Please subscribe to gain access.